Idecabtagene vicleucel car
Full descriptor
Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Details
- Code
- Q2055
- Short descriptor
- Idecabtagene vicleucel car
- Code set
- HCPCS Level II
- Release
- July 2026
- Status
- Active
- Added
- Jan 1 2022
Nearby codes
Code sets are published in blocks, so neighbours are usually related.
Lisocabtagene mara car pos t
Ciltacabtagene car-pos t
Brexucabtagene car pos t
Afamitresgene autoleucel
Home ivig, services/supplies
Obecbtge autol up to 400 mil
Doxorubicin inj 10mg
Imported lipodox inj
Sources
- CMS HCPCS Level II — July 2026, public domain
Reference information only. Not billing advice. Verify against the payer before you file.